These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 7509339

  • 1. Delayed treatment with AMPA, but not NMDA, antagonists reduces neocortical infarction.
    Xue D, Huang ZG, Barnes K, Lesiuk HJ, Smith KE, Buchan AM.
    J Cereb Blood Flow Metab; 1994 Mar; 14(2):251-61. PubMed ID: 7509339
    [Abstract] [Full Text] [Related]

  • 2. AMPA antagonists: do they hold more promise for clinical stroke trials than NMDA antagonists?
    Buchan AM, Lesiuk H, Barnes KA, Li H, Huang ZG, Smith KE, Xue D.
    Stroke; 1993 Dec; 24(12 Suppl):I148-52. PubMed ID: 7504338
    [Abstract] [Full Text] [Related]

  • 3. Treatment with an AMPA antagonist 12 hours following severe normothermic forebrain ischemia prevents CA1 neuronal injury.
    Li H, Buchan AM.
    J Cereb Blood Flow Metab; 1993 Nov; 13(6):933-9. PubMed ID: 7691852
    [Abstract] [Full Text] [Related]

  • 4. The pharmacology of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate antagonists and their role in cerebral ischaemia.
    Gill R.
    Cerebrovasc Brain Metab Rev; 1994 Nov; 6(3):225-56. PubMed ID: 7529037
    [Abstract] [Full Text] [Related]

  • 5. Motor performance, histologic damage, and calcium influx in rats treated with NBQX after focal ischemia.
    DeGraba TJ, Ostrow P, Hanson S, Grotta JC.
    J Cereb Blood Flow Metab; 1994 Mar; 14(2):262-8. PubMed ID: 8113322
    [Abstract] [Full Text] [Related]

  • 6. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
    Potschka H, Löscher W, Wlaź P, Behl B, Hofmann HP, Treiber HJ, Szabo L.
    Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
    [Abstract] [Full Text] [Related]

  • 7. Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia.
    Nellgård B, Wieloch T.
    J Cereb Blood Flow Metab; 1992 Jan; 12(1):2-11. PubMed ID: 1345757
    [Abstract] [Full Text] [Related]

  • 8. Cerebroprotective effect of a non-N-methyl-D-aspartate antagonist, NBQX, after focal ischaemia in the rat.
    Smith SE, Meldrum BS.
    Funct Neurol; 1993 Jan; 8(1):43-8. PubMed ID: 8330753
    [Abstract] [Full Text] [Related]

  • 9. Disruption of operant oral self-administration of ethanol, sucrose, and saccharin by the AMPA/kainate antagonist, NBQX, but not the AMPA antagonist, GYKI 52466.
    Stephens DN, Brown G.
    Alcohol Clin Exp Res; 1999 Dec; 23(12):1914-20. PubMed ID: 10630610
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A comparison of intravenous NBQX and GYKI 53655 as AMPA antagonists in the rat spinal cord.
    Chizh BA, Cumberbatch MJ, Headley PM.
    Br J Pharmacol; 1994 Jul; 112(3):843-6. PubMed ID: 7522860
    [Abstract] [Full Text] [Related]

  • 12. Role of glutamate receptors in the development and maintenance of bladder overactivity after cerebral infarction in the rat.
    Yokoyama O, Mizuno H, Komatsu K, Akino H, Tanase K, Namiki M.
    J Urol; 2004 Apr; 171(4):1709-14. PubMed ID: 15017271
    [Abstract] [Full Text] [Related]

  • 13. [Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof].
    Xiao ZY, Sun CK, Xiao XW, Lin YZ, Li S, Ma H, Song GR, Cheng R.
    Zhonghua Yi Xue Za Zhi; 2006 Sep 19; 86(35):2479-84. PubMed ID: 17156678
    [Abstract] [Full Text] [Related]

  • 14. Delayed antagonism of AMPA/kainate receptors reduces long-term functional deficits resulting from spinal cord trauma.
    Wrathall JR, Teng YD, Marriott R.
    Exp Neurol; 1997 Jun 19; 145(2 Pt 1):565-73. PubMed ID: 9217092
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Amelioration of functional deficits from spinal cord trauma with systemically administered NBQX, an antagonist of non-N-methyl-D-aspartate receptors.
    Wrathall JR, Teng YD, Choiniere D.
    Exp Neurol; 1996 Jan 19; 137(1):119-26. PubMed ID: 8566203
    [Abstract] [Full Text] [Related]

  • 18. Blocking the trigeminal EPSP in rat abducens motoneurons in vivo with the AMPA antagonists NBQX and GYKI 53655.
    Ruiz A, Durand J.
    Brain Res Bull; 2000 May 15; 52(2):99-107. PubMed ID: 10808079
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.